Providers for Readers Weighing Insurance Against Cash Pay
Nothing on this board is a coverage promise; these are published cash prices to hold up against whatever a reader's own plan says it will pay.
Compounded GLP-1 medication is generally not billed to insurance, so the cash price is the price. That is the practical starting point for anyone deciding between paying a telehealth platform directly and pursuing a covered product through their own plan. A published, checkable cash figure is what makes that decision possible at all.
Two things get confused here, and separating them is most of the work. A provider that helps prepare a prior-authorization request is doing paperwork. A plan that approves coverage is making a decision. Help with a form is not an approval, is not a prediction of one, and has no bearing on the outcome. Only the plan can say what it will pay for.
The order of operations matters. Ask the plan about a specific named product first and get its answer in concrete terms, including what the patient would owe. Then set that answer beside the cash figures collected here. Comparing a real quote against a real quote is the only version of this comparison that decides anything.
Quick picks
compareglp may earn a commission when a reader signs up with a provider through a link on this site. None of the 16 providers reviewed here are paid partners today. See how this works.
Quick picks: top providers for insurance-friendly, by score
compareglp may earn a commission when a reader signs up with a provider through a link on this site. None of the 16 providers reviewed here are paid partners today. See how this works.
A telehealth platform selling compounded semaglutide and tirzepatide at a single flat monthly price regardless of dose, shipping in all 50 states, and disclosing more than one compounding pharmacy partner by name.
Best for: flat-rate compounded GLP-1 with more than one named pharmacy partner
$119/moper month
Strengths
Discloses more than one compounding pharmacy partner by name rather than describing them only in general terms
One price per drug that holds regardless of dose, so titrating up does not raise the bill
Ships to all 50 states
Worth knowing
Received an FDA warning letter (No. 721795, issued February 2026) over how its site displayed Belle branding alongside compounded semaglutide and tirzepatide, which the agency found implied Belle itself manufactured the drugs
The $199 tirzepatide rate requires a 3-month bundle; a shorter commitment costs more per month
Compounded medications are not FDA-approved finished drug products
compareglp may earn a commission when a reader signs up with a provider through a link on this site. None of the 16 providers reviewed here are paid partners today. See how this works.
A nationwide telehealth platform that prints its introductory rate, its standing rate and its brand-name cash prices on a single page, and states that no membership or additional fee sits on top of the medication figure.
Best for: readers who want the introductory rate and the standing rate published together before they commit
$149/moper month, standing rate; a new-customer starter program runs lower for two months
Strengths
Prints the introductory rate and the rate that follows it side by side, which is the disclosure most sellers in this comparison leave to a footnote
States that no membership fee or additional charge sits on top of the medication price
Publishes cash figures for brand-name Zepbound and Wegovy on the same page as the compounded rates
Worth knowing
The compounding pharmacy is described by licensing class and standards rather than named
The starter and transfer rates are limited to new customers, so a returning patient pays the standing rate from the first fill
The starter program is tied to the lowest available dose, which is not where most patients stay
compareglp may earn a commission when a reader signs up with a provider through a link on this site. None of the 16 providers reviewed here are paid partners today. See how this works.
A large telehealth weight-loss platform offering one flat price for either compounded semaglutide or tirzepatide, plus separate access to brand-name GLP-1s such as Wegovy, Ozempic, Zepbound, and Mounjaro at their own listed prices.
Best for: comparing a flat compounded price against brand-name GLP-1 options in one place
$169/moper month, 12-month prepaid plan
Strengths
One flat program price covers either semaglutide or tirzepatide, so tirzepatide does not carry the higher price it often does elsewhere
Also offers brand-name GLP-1s (Wegovy, Ozempic, Zepbound, Mounjaro) for readers who want an FDA-approved product instead of a compounded one
Displays a LegitScript seal and holds BBB accreditation
Worth knowing
The lowest advertised price requires a 12-month prepaid commitment; paying month to month costs about $120 more per month
Describes its compounding pharmacies only as ‘503A-licensed,’ without naming which pharmacy fills a given order
Its own pricing pages are not fully consistent with each other — one page lists Wegovy starting near $199/month while the homepage carousel advertises $650/month and up
compareglp may earn a commission when a reader signs up with a provider through a link on this site. None of the 16 providers reviewed here are paid partners today. See how this works.
A compounded-only telehealth platform selling semaglutide and tirzepatide at a flat annual-plan rate, with an unusually large published library of cost and comparison material around it.
Best for: readers ready to commit to a year and who want semaglutide and tirzepatide priced close together
$99/moper month on the annual plan; no month-to-month rate is published
Strengths
One of the smallest gaps between a semaglutide and a tirzepatide rate in this comparison, so switching compounds costs little
States that the price is flat across dose levels and covers shipping, provider messaging and dose adjustments
Says it is available in all 50 states at the same rate rather than varying the price by location
Worth knowing
Both published figures are annual-plan rates. A month-to-month price appears on none of its treatments, FAQ or cost-guide pages, so the cost of a shorter commitment is unknown before intake
The compounding pharmacy is not named
Trimi publishes its own comparison table ranking rival providers, and at least one competitor rate in it sits well above what that competitor advertises today — read it as marketing, not as a price source
compareglp may earn a commission when a reader signs up with a provider through a link on this site. None of the 16 providers reviewed here are paid partners today. See how this works.
A telehealth brand operated by Medccm Inc. selling compounded semaglutide and tirzepatide on a plan-length pricing ladder — the longer the prepaid term, the lower the monthly rate — plus a newer, lower-dose product line at the same structure.
Best for: readers who want to compare a published plan-length pricing ladder before committing
$119/moper month, 3-month plan
Strengths
The legal entity behind the brand (Medccm Inc.) is disclosed rather than left anonymous
A public Trustpilot profile with several hundred reviews exists rather than no third-party review presence at all
The checkout charge is described as an authorization hold, released with no charge if a provider declines the patient
Worth knowing
A non-refundable $50 fee applies to cancel after intake is approved
The compounding pharmacy that fills the prescription is never named
The cheapest rate on the ladder requires a 12-month prepaid commitment; paying month to month costs noticeably more
compareglp may earn a commission when a reader signs up with a provider through a link on this site. None of the 16 providers reviewed here are paid partners today. See how this works.
A peptide-medicine platform connecting patients to a multi-state clinician network for compounded semaglutide and tirzepatide, offered as a weekly injection or a daily dissolving tablet, alongside a broader catalog of longevity peptides.
Best for: readers who want a nationwide clinician network and a broader peptide catalog beyond GLP-1s
$170/moper month, ongoing rate after a lower first month
Strengths
Clinician network is licensed across all 50 states and DC through the Interstate Medical Licensure Compact
The published subscription price does not change as the dose is increased
Both an injectable and an oral dissolving-tablet format are available for each compound
Worth knowing
YourHealthRx is the platform layer — eligibility and prescribing run through partner clinical workflows, not YourHealthRx itself
The compounding pharmacy that fills the prescription is not named
The advertised rate is a discounted first month; the ongoing monthly price is higher
compareglp may earn a commission when a reader signs up with a provider through a link on this site. None of the 16 providers reviewed here are paid partners today. See how this works.
A telehealth platform selling compounded semaglutide and tirzepatide at a single price that stays the same regardless of dose, with limited additional program detail published beyond price and state availability.
Best for: an initial price comparison, with program details worth confirming directly with Amble before enrolling
$179/mostarting at, per month
Strengths
Advertises availability in all 50 states
One price per drug that does not rise with dose
States that medication, supplies, and shipping are included in the quoted price
Worth knowing
Publishes little beyond price and state availability — no named pharmacy, no accreditation seal, and no published detail on the intake or cancellation process
The tirzepatide price is a starting figure; the site states the range runs up to $329 per month
compareglp may earn a commission when a reader signs up with a provider through a link on this site. None of the 16 providers reviewed here are paid partners today. See how this works.
A bilingual English/Spanish telehealth clinic selling compounded semaglutide and tirzepatide at a price that does not rise as the dose increases, with care delivered directly in Spanish rather than through translation.
Best for: Spanish-speaking patients who want one fixed price for a full year of treatment
$199/moper month, 52-week plan
Strengths
Clinicians treat patients directly in Spanish as a primary language, not through machine translation
Displays a LegitScript seal that resolves to a live, matching certificate rather than a static badge image
The price holds for the full course of treatment instead of rising as the dose is increased
Worth knowing
The lowest advertised rate requires a 52-week commitment; paying month to month costs $80 more for semaglutide and $70 more for tirzepatide
The compounding pharmacy is verified by NPI number but is not named on the site
Compounded semaglutide and tirzepatide are not FDA-approved finished drug products
compareglp may earn a commission when a reader signs up with a provider through a link on this site. None of the 16 providers reviewed here are paid partners today. See how this works.
A nationwide telehealth provider selling compounded semaglutide and tirzepatide as either a weekly injection or a daily oral dose, each formulated with added NAD, B-12, and L-carnitine rather than as a single-ingredient GLP-1.
Best for: patients who want unlimited visits and labs included without a plan-length commitment
$299/moper month, month-to-month
Strengths
Licensed to ship in all 50 states
Unlimited provider visits and Labcorp lab work are included in the monthly price rather than billed separately
Offers both an injectable and an oral form of each compound
Worth knowing
The compounded product bundles NAD, B-12, and L-carnitine into the injection rather than offering a single-ingredient GLP-1
Does not publish the name of its compounding pharmacy or display a third-party accreditation seal
compareglp may earn a commission when a reader signs up with a provider through a link on this site. None of the 16 providers reviewed here are paid partners today. See how this works.
Every provider on this page earns one point for each of the four items below that it satisfies, out of a possible four. That count is scaled to a score out of 10 — two of four satisfied is a 5.0, for example. The score never factors in an FDA warning letter: a letter discloses, it does not disqualify.
Names its compounding pharmacy. The provider publishes the name of the pharmacy that compounds and fills the prescription, not only a general licensing claim.
Publishes its price. A reader can find a real monthly figure on the provider’s own site before starting an intake, with its billing cycle or plan term stated.
Ships to all 50 states. The provider is licensed to prescribe and ship in every state, not a subset.
Offers a brand-name option. The provider also lists an FDA-approved brand-name GLP-1 (such as Wegovy, Ozempic, Zepbound, or Mounjaro), not only a compounded product.
Every rubric item above is a fact declared from research, checked against the provider’s own site — never a word count or a keyword match run over review text. Prices are re-verified on the date printed next to each figure and always carry their billing cycle or plan term. Ranking position never depends on which providers pay a commission: none of the 16 providers reviewed on this site is a paid partner today (see the disclosure above), and the same rule holds if that changes.
This board gathers providers that publish a clear cash price and ship nationwide, so the figure shown is usable regardless of where a reader lives. Being listed here does not mean a provider bills insurance, files claims, or has any relationship with a plan. Nothing on the board ranks insurers, describes any plan's benefits, or states what any policy covers. The one thing it offers is a set of verifiable cash prices to compare against an answer that has to come from the plan itself.
How to use this board
Get the plan's answer about a specific named product first, then bring it back to these figures.
Confirm a provider ships to your state before comparing its price with anything.
Read the qualifier: a cash price on a prepaid year is a different number from a month-to-month one.
Ask what a cash figure includes, such as visits, lab work, supplies, and shipping, so the comparison covers the same ground on both sides.
Things to watch for
Insurance-friendly is a marketing phrase rather than a benefit. On most sites it describes help with paperwork or a superbill, not payment by a plan, and the two have very different consequences for a bill.
Submitting a prior-authorization request is not the same as having one approved. The decision belongs to the plan, and a provider that helps fill in the form has no say in the outcome and cannot promise one.
Accepts insurance on a checkout page sometimes means only that an HSA or FSA card will run, not that a claim is filed on a patient's behalf. Ask directly which of the two is being offered.
A cash price and a copay are different kinds of number. What a patient pays under a plan depends on that plan's own rules, so a figure quoted by anyone other than the plan is an estimate rather than an answer.
Frequently asked questions
Will my insurance cover a provider on this board?
Ask the plan, because that is the only source that can answer it. Compounded GLP-1 medication is generally not billed to insurance, and the providers here publish cash prices rather than filing claims. If coverage is the goal, ask the plan about a specific brand-name product by name, then compare its answer against the figures here.
Why call this board insurance-friendly if these providers do not bill insurance?
Because a clear cash price is what makes a coverage decision comparable. Every provider here publishes a real figure and ships nationwide, which gives a reader one side of a comparison they can trust. The other side has to come from the plan. The name describes that job, not a claim that any policy pays.
Can a provider here help with a prior authorization?
Ask the provider directly, since practice varies and this kind of support usually applies to approved brand-name products rather than compounded ones. Whatever help is offered, keep the distinction clear: preparing a request is administrative work, and the approval decision sits with the plan alone.
Can I pay with an HSA or FSA card?
That depends on the account's rules and how the expense is classified, so confirm it with the plan administrator before assuming a card will run. A provider stating that it accepts such a card is describing a payment method. It is not telling a patient the expense is eligible under their account.
Is paying cash cheaper than going through a plan?
Sometimes, and sometimes not, and the answer is specific to each plan and each product. A cash price is fixed and published. What a plan charges depends on its own design and the product in question. The comparison only works once both numbers are real, which means getting the plan's figure before deciding.
Belle Health leads this board today. Its full price, with its qualifier, is above — visiting a provider’s site does not commit you to anything.
compareglp may earn a commission when a reader signs up with a provider through a link on this site. None of the 16 providers reviewed here are paid partners today. See how this works.
